Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥851.3B | ¥999.2B | −14.8% |
| Operating Income | ¥12.2B | ¥13.8B | −11.3% |
| Ordinary Income | ¥10.8B | ¥10.2B | +5.5% |
| Net Income | ¥7.2B | ¥3.7B | +94.1% |
| ROE (annualized) | 5.6% | 3.2% | - |
Executive Summary
Despite declining revenue, the Company maintained operating profitability through an improved gross margin and restraint in SG&A expenses; however, operating income itself declined from the previous year, and therefore does not indicate a strong earnings base. Revenue was ¥851.3B (-14.8% YoY), operating income was ¥12.2B (-11.3%), ordinary income was ¥10.8B (+5.5%), and net income was ¥7.2B (+94.1%). The substantial increase in net income was largely attributable to the reversal of the previous year's extraordinary loss and a gain on the sale of fixed assets of ¥0.7B in the current period, and does not necessarily reflect the Company's operating strength.
Factors Affecting Performance
【Revenue】Revenue was ¥851.3B, down -14.8% YoY, and was significantly affected by customer production plans and demand fluctuations under a single-segment structure centered on the EMS Business. Gross profit was ¥52.4B, representing a decline of only -3.1% from ¥54.0B in the previous year, substantially below the rate of decline in revenue. The gross margin improved by approximately 0.7pt to 6.2%, compared with 5.4% in the previous year, indicating greater efficiency in the cost structure.
【Profit and Loss】SG&A expenses were ¥40.2B, nearly flat at -0.2% YoY, and the operating margin was maintained at 1.4%. However, operating income declined -11.3% to ¥12.2B from ¥13.8B in the previous year, indicating that the margin improvement did not translate into an increase in operating income. Ordinary income was ¥10.8B (+5.5%), as interest expenses declined from ¥4.8B to ¥3.2B. Net income was ¥7.2B (+94.1%), but this was boosted by the reversal of the previous year's extraordinary loss of ¥1.2B and the current period's gain on the sale of fixed assets of ¥0.7B; these factors should be distinguished from an improvement in recurring earnings power. Overall, the results can be characterized as declining revenue and lower earnings at the operating level.
Segment Analysis
The Company has a single-segment structure, as businesses other than the EMS Business are not material, and does not disclose information by segment.
Key Financial Indicators
【Profitability】The operating margin of 1.4%, net profit margin of 0.8%, and gross margin of 6.2%—improved from 5.4% in the previous year—are all low, reflecting the low-margin structure characteristic of the EMS Business.【Cash Flow Quality】A gain on the sale of fixed assets of ¥0.7B was recorded against pretax income of ¥11.1B, and it should be noted that net income of ¥7.2B includes a temporary factor.【Investment Efficiency】ROE (annualized) of 5.6% is supported by high financial leverage. Since it consists of a net profit margin of 0.8% × total asset turnover × high leverage, the Company's fundamental earnings power is limited.【Financial Soundness】The equity ratio improved to 22.4% from 20.7% in the previous year; however, current assets of ¥479.0B versus current liabilities of ¥489.9B resulted in a current ratio of approximately 97.8%, indicating negative working capital.
Cash Flow Analysis
Although detailed disclosure of the cash flow statement is not available, the balance sheet movements suggest that cash and deposits remained broadly flat at ¥110.3B, while short-term borrowings increased +17.9% YoY to ¥217.9B and long-term borrowings declined -13.8% to ¥93.1B, indicating a shift toward shorter-term financing. Accounts receivable, finished goods inventories, and work-in-process inventories increased by +19.5%, +51.4%, and +76.9%, respectively, suggesting that the accumulation of working capital may be affecting cash management. Accounts payable also increased +14.5%, providing a degree of support for working capital through the use of trade payables. Property, plant and equipment increased +5.5%, indicating continued investment primarily in machinery and equipment.
Earnings Quality
The difference between ordinary income and net income was attributable to extraordinary gains and losses. In the current period, the Company recorded a gain on the sale of fixed assets of ¥0.7B as an extraordinary gain and a loss on the disposal and sale of fixed assets of ¥0.2B as an extraordinary loss. Non-operating income of ¥10.8B represented 1.3% of revenue and was primarily composed of interest income of ¥0.7B, making it relatively easy to assess as recurring income. Meanwhile, interest expenses of ¥3.2B, among non-operating expenses of ¥12.3B, are a continuing burden arising from the financial structure. Net income increased substantially by +94.1% YoY to ¥7.2B, but the increase was contributed by the reversal of the previous year's extraordinary loss and the gain on the sale of fixed assets in the current period. Accordingly, it would not be appropriate to interpret the net income growth rate as an equivalent improvement in recurring earnings. Operating income declined -11.3%, and the deterioration at the operating level should be closely monitored in assessing earnings quality.
Earnings Forecast and Guidance
The full-year plan calls for revenue of ¥1150.0B (-12.8% YoY), operating income of ¥18.0B (-16.2%), and ordinary income of ¥15.0B (-8.9%). The Q3 cumulative progress rates were 74.0% for revenue, 67.8% for operating income, 71.7% for ordinary income, and 71.8% for net income. While revenue was broadly in line with standard progress of approximately 75%, operating income progress was below this level. Achieving the plan will require approximately ¥5.8B in operating income in Q4, making this a period in which profitability must improve beyond the Q3 cumulative operating margin of 1.4%.
Shareholder Returns
The Q2 dividend was ¥5.00 per share, and the full-year dividend forecast is ¥10.00 per share. Based on Q3 cumulative net income attributable to owners of the parent of ¥7.2B, the payout ratio is approximately 19.7%. Based on forecast full-year net income of ¥10.0B, the forecast payout ratio is approximately 28.1%; both are below the generally cited level of approximately 60%. There has been no disclosure regarding share buybacks, and the assessment is therefore based solely on dividends. Given the low current ratio and reliance on short-term borrowings, the absolute dividend level is not excessive, but this is a period in which securing working capital and financial flexibility should take priority.
Risk Factors
-
Liquidity risk: The current ratio is 97.8%, below 1.0x, and working capital is negative at ¥10.9B. Short-term borrowings of ¥217.9B account for the majority of short-term liabilities, while cash and deposits of ¥110.3B amount to approximately half of short-term liabilities.
-
Leverage risk: Interest-bearing debt is approximately ¥311B against an equity ratio of 22.4%, and the D/E ratio is above 3x. Interest coverage relative to interest expenses of ¥3.2B cannot be considered high, and resilience to rising interest rates and deteriorating profitability is limited.
-
Earnings volatility risk: The Company operates as a single EMS Business segment. Under a low-margin structure characterized by a gross margin of 6.2% and an operating margin of 1.4%, fluctuations in customers' production plans, component supply and demand, and foreign exchange rates—the Company recorded a foreign exchange loss of ¥0.3B in the current period—may have a significant impact on earnings.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 1.4% | 8.6% (4.3%–12.7%) | −7.2pt |
| Net Profit Margin | 0.8% | 6.4% (2.8%–10.3%) | −5.6pt |
Compared with the industry median, profitability is substantially below the median in both operating and net profit margins.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −14.8% | 3.3% (-2.1%–8.9%) | −18.1pt |
Revenue growth also falls substantially below the industry median, placing the Company among the group with the largest revenue declines within the industry.
※Source: Compiled by the Company
Key Takeaways from the Results
-
The results indicate cost management efforts, as the Company improved its gross margin YoY and maintained its operating margin by keeping SG&A expenses broadly flat despite declining revenue.
-
Although net income increased substantially by +94.1% YoY, operating income declined -11.3%. The financial results clearly indicate that extraordinary gains and losses were the primary drivers of the increase in net income.
-
The combination of a current ratio of 97.8%, an increase in short-term borrowings (+17.9%), and a decrease in long-term borrowings (-13.8%) indicates that the financing structure is becoming more short-term oriented. This should be monitored together with the Company's ability to secure profitability in Q4 toward achieving the full-year plan.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (bearish) | ¥541 |
| base (base case) | ¥548 |
| bull (bullish) | ¥557 |
| Valuation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥612 |
| Adjusted Forecast EPS | ¥36.7 |
| Cost of Equity r | 9.77% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 1.00%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 29.4% |
| Forecast EPS Confidence Adjustment | ×1.080 (based on the industry peers' historical guidance achievement rates) |
| implied PBR / PER | 0.90x / 14.9x |
Sensitivity: ¥533–¥564 at ±1% for the cost of equity, and ¥546–¥549 at ±0.1 for ω.
Notes:
- As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the quarter-end are used (there is a timing gap relative to the full-year forecast).
- As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Valuation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.
---End of Report---